Showing results (411-420 of 586) with videos related to

Sort By:
Pageof 59
The Journal of Nutritional Biochemistry|May 8, 2013
Antioxidant system response is modified by dietary fat in adipose tissue of metabolic syndrome patientsPatricia Peña-Orihuela, Antonio Camargo, Oriol Alberto Rangel-Zuñiga, et al.
European Journal of Nutrition|October 5, 2021
A plasma fatty acid profile associated to type 2 diabetes development: from the CORDIOPREV studyAlejandro Villasanta-Gonzalez, Juan Francisco Alcala-Diaz, Cristina Vals-Delgado, et al.
Atherosclerosis|November 13, 2012
Lipid metabolism after an oral fat test meal is affected by age-associated features of metabolic syndrome, but not by ageAna I Perez-Caballero, Juan F Alcala-Diaz, Pablo Perez-Martinez, et al.
Aging|October 27, 2020
Interplay between gonadal hormones and postnatal overfeeding in defining sex-dependent differences in gut microbiota architectureJose A Santos-Marcos, Alexia Barroso, Oriol A Rangel-Zuñiga, et al.
Clinical Nutrition (Edinburgh, Scotland)|January 7, 2017
Beneficial effect of CETP gene polymorphism in combination with a Mediterranean diet influencing lipid metabolism in metabolic syndrome patients: CORDIOPREV studyAntonio Garcia-Rios, Juan Francisco Alcala-Diaz, Francisco Gomez-Delgado, et al.
Circulation|February 21, 2023
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J Milling, Saskia Middeldorp, Lizhen Xu, et al.
Cardiovascular Diabetology|October 14, 2024
Modulation of circulating levels of advanced glycation end products and its impact on intima-media thickness of both common carotid arteries: CORDIOPREV randomised controlled trialFrancisco M Gutierrez-Mariscal, Alejandro Lopez-Moreno, Jose D Torres-Peña, et al.
BMC Geriatrics|April 24, 2020
Age-dependent effect of metabolic phenotypes on carotid atherosclerotic disease in coronary heart disease patients (CORDIOPREV study)Francisco M Gutierrez-Mariscal, Antonio García-Ríos, Purificación Gómez-Luna, et al.
BMC Medicine|October 27, 2022
Metabolomics analysis of type 2 diabetes remission identifies 12 metabolites with predictive capacity: a CORDIOPREV clinical trial studyMarina Mora-Ortiz, Juan F Alcala-Diaz, Oriol Alberto Rangel-Zuñiga, et al.
Pageof 59